Elin Haf Davies

Chief Executive Officer

United Kingdom

Elin Haf has 20+ years experience of drug development in paediatrics and rare disease, clinically, academically and as a regulator at the European Medicine Agency.

Elin Haf now serves as the Chair of Metabolic Support UK and the CEO of Aparito – a medtech company supporting centralised clinical trials and the development of digital biomarkers.

Disclosure statement:

Elin Haf is a shareholder for Aparito.